2022
DOI: 10.3389/fonc.2022.774307
|View full text |Cite|
|
Sign up to set email alerts
|

Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer

Abstract: To investigate the role of N6-methyladenosine (m6A)- related long non-coding RNAs (lncRNAs) in bladder cancer (BC). 50 m6A-related lncRNAs were screened out and were correlated with prognosis from BC samples in The Cancer Genome Atlas (TCGA). The lncRNAs were subdivided into cluster 1 and cluster 2 with consensus cluster analysis, and it was found that lncRNAs in cluster 2 were associated with poor prognosis and increased PD-L1 expression. Gene set enrichment analysis (GSEA) revealed tumor-related pathways in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 54 publications
0
2
0
Order By: Relevance
“…LncRNAs are important in multi-gene regulatory networks, and they can be utilized to diagnose and predict survival in a variety of cancers (14). Multiple lncRNAs signature have been researched in bladder cancer (15)(16)(17). However, the role of ERS-related lncRNA in bladder cancer remains to be studied.…”
Section: Introductionmentioning
confidence: 99%
“…LncRNAs are important in multi-gene regulatory networks, and they can be utilized to diagnose and predict survival in a variety of cancers (14). Multiple lncRNAs signature have been researched in bladder cancer (15)(16)(17). However, the role of ERS-related lncRNA in bladder cancer remains to be studied.…”
Section: Introductionmentioning
confidence: 99%
“…m6A modifications have been reported to play a crucial role in diverse biological processes. The development of various tumors is accompanied by m6A methylation modifications, including in colorectal cancer, 17 bladder cancer, 18 and prostate cancer 19 . Moreover, m6A modifications has been found in many CNS diseases 15 .…”
Section: Introductionmentioning
confidence: 99%